2GFB image
Deposition Date 1994-07-07
Release Date 1994-09-30
Last Version Date 2024-10-30
Entry Detail
PDB ID:
2GFB
Keywords:
Title:
CRYSTAL STRUCTURE OF A CATALYTIC FAB HAVING ESTERASE-LIKE ACTIVITY
Biological Source:
Source Organism:
Mus musculus (Taxon ID: 10090)
Method Details:
Experimental Method:
Resolution:
3.00 Å
R-Value Work:
0.21
R-Value Observed:
0.21
Space Group:
P 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:IGG2A CNJ206 FAB (LIGHT CHAIN)
Chain IDs:A, C, E, G, I, K, M, O
Chain Length:214
Number of Molecules:8
Biological Source:Mus musculus
Polymer Type:polypeptide(L)
Molecule:IGG2A CNJ206 FAB (HEAVY CHAIN)
Chain IDs:B, D, F, H, J, L, N, P
Chain Length:219
Number of Molecules:8
Biological Source:Mus musculus
Ligand Molecules
Primary Citation
Crystal structure of a catalytic antibody Fab with esterase-like activity.
Structure 2 175 183 (1994)
PMID: 8069632 DOI: 10.1016/S0969-2126(00)00019-8

Abstact

BACKGROUND Antibodies with catalytic properties can be prepared by eliciting an antibody response against 'transition state analog' haptens. The specificity, rate and number of reaction cycles observed with these antibodies more closely resemble the properties of enzymes than any of the many other known enzyme-mimicking systems. RESULTS We have determined to 3 A resolution the first X-ray structure of a catalytic antibody Fab. This antibody catalyzes the hydrolysis of a p-nitrophenyl ester. In conjunction with binding studies in solution, this structure of the uncomplexed site suggests a model for transition state fixation where two tyrosines mimic the oxyanion binding hole of serine proteases. A comparison with the structures of known Fabs specific for low molecular weight haptens reveals that this catalytic antibody has an unusually long groove at its combining site. CONCLUSION Since transition state analogs contain elements of the desired product, product inhibition is a severe problem in antibody catalysis. The observation of a long groove at the combining site may relate to the ability of this catalytic antibody to achieve multiple cycles of reaction.

Legend

Protein

Chemical

Disease

Primary Citation of related structures